HM Payson & Co’s Avanos Medical AVNS Stock Holding History

HM Payson & Co’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,250	Closed	-$14K	–	1133
2025 Q4	$14K	Hold	1,250	–	–	﹤0.01%	886
2025 Q3	$14.4K	Buy	+1,250	New	+$14.6K	﹤0.01%	873
2023 Q4	–	Sell	-48	Closed	-$971	–	969
2023 Q3	$971	Buy	+48	New	+$1.09K	﹤0.01%	964
2023 Q2	–	Sell	-3	Closed	-$90	–	1001
2023 Q1	$90	Hold	3	–	–	﹤0.01%	1007
2022 Q4	$81	Hold	3	–	–	﹤0.01%	922
2022 Q3	$0	Hold	3	–	–	﹤0.01%	973
2022 Q2	$0	Hold	3	–	–	﹤0.01%	1041
2022 Q1	$0	Sell	3 -12	-80%	-$386	﹤0.01%	1053
2021 Q4	$1K	Sell	15 -54	-78%	-$1.75K	﹤0.01%	1033
2021 Q3	$2K	Hold	69	–	–	﹤0.01%	986
2021 Q2	$3K	Hold	69	–	–	﹤0.01%	934
2021 Q1	$3K	Hold	69	–	–	﹤0.01%	992
2020 Q4	$3K	Sell	69 -104	-60%	-$4.33K	﹤0.01%	965
2020 Q3	$6K	Hold	173	–	–	﹤0.01%	874
2020 Q2	$5K	Hold	173	–	–	﹤0.01%	794
2020 Q1	$5K	Hold	173	–	–	﹤0.01%	804
2019 Q4	$6K	Sell	173 -59	-25%	-$2.14K	﹤0.01%	843
2019 Q3	$9K	Sell	232 -34	-13%	-$1.3K	﹤0.01%	821
2019 Q2	$12K	Buy	+266	New	+$11.4K	﹤0.01%	793

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

HM Payson & Co's AVNS Position: Q1 2026 in Review

HM Payson & Co sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 1,250 shares — an estimated $14K sold.

HM Payson & Co first reported a position in AVNS in Q2 2019 and held it in 19 quarters. The position peaked at $14.4K in Q3 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

HM Payson & Co reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
HM Payson & Co sold 1,250 Avanos Medical shares in Q1 2026, an estimated $14K.
HM Payson & Co first reported a position in Avanos Medical in Q2 2019 and held it in 19 quarters.
HM Payson & Co's Avanos Medical position peaked at $14.4K in Q3 2025.
257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on HM Payson & Co's 13F filing for Q1 2026, filed 13 Apr 2026.